Pembrolizumab,PDS0101
pds biotech,merck
['headandneck', 'pdsbio', 'pds bio']
chief medical officer dr. lauren v. wood speaks with fellow #asco23 attendees in front of the poster she co-authored about interim versatile-002 data for recurrent/metastatic hpv16 #headandneckcancer patients. conference call scheduled 6/6 8 a.m. et: 
PDS Biotech is a clinical-stage biotech company developing cancer therapies and infectious disease vaccines based on Versamune®, a T-cell activating technology.